Restriction on the use of M-N-MA in Cosmetic Products
The European Commission has published the Commission Regulation (EU) 2022/135. This regulation amends the European Cosmetic Regulation, adding a new entry to Annex III. The use of Methyl-N-methylanthranilate (M-N-MA) in cosmetic products will be subject to restrictions.
Picture of Marta Pinto

Marta Pinto

Regulatory Affairs Associate

METHYL-N-METHYLANTHRANILATE (M-N-MA)

Methyl-N-methylanthranilate (CAS number: 85-91-6), commonly called M-N-MA, is as fragrance ingredient used in several types of personal care and cosmetic products (e.g. fine fragrances, shampoos, soaps and others). It is also used in other types of products, like household cleaners and detergents.

At the moment, this ingredient is not currently included in the annexes of the European Cosmetics Regulation (No. 1223/2009), which means that its use is not restricted in cosmetic products placed in the European Union (EU).

The European Commission’s Scientific Committee on Consumer Safety (SCCS) has published opinions regarding the safety of M-N-MA use in cosmetic products.

In 2006, the SCCS concluded that M-N-MA was phototoxic, as demonstrated in in vitro and in vivo testing. Moreover, the SCCS stated that this ingredient should not be deliberately added to leave-on cosmetic products, because there is always the potential for light exposure.

Up to a maximum concentration of 0.1%, the use of M-N-MA in leave-on products (including deodorants and antiperspirants) was deemed as safe by the SCCS in 2011. But a risk could not be excluded for the use of this ingredient in sunscreen/sun care products or products (including fragrances) intended for use on areas exposed to light (especially face and neck).

Since M-N-MA is prone to nitrosation, so the SCCS indicated that it should not be used in combination with nitrosating agents and the nitrosamine content should be below 50 μg/kg.

In 2020, the SCCS issued a scientific advice on its last opinion on M-N-MA. The Scientific Committee stated that “Methyl-N-methylanthranilate should not be used in suncreen products and products marketed for exposure to natural/artificial UV light“. On other cosmetic products, SCCS considers M-N-MA safe when used up to 0.1% in leave-on preparations and up to 0.2% in rinse-off products.

UPCOMING AMENDMENT TO COSMETICS REGULATION

The European Commission has published the Commission Regulation (EU) 2022/135, amending the European Cosmetic Regulation ((EC) No 1223/2009) as regards the use of Methyl-N-methylanthranilate in cosmetic products.

Following the SCCS opinions and scientific advice, the Commission considers that “there is a potential risk to human health arising from the use of M-N-MA in sunscreen products and products marketed for exposure to natural or artificial UV light and in other in other cosmetic products where the concentration of the substance is more than 0,1 % for leave-on products and 0,2 % for rinse-off products. Therefore, such use of M-N-MA should be prohibited.“.

Moreover, there is also a potential risk to human health arising from the use of this ingredient with nitrosating agents and the Commission states that such use of M-N-MA should be prohibited.

An entry will be added to Annex III (list of substances which cosmetic products must not contain except subject to the restrictions laid down) of the EU Cosmetic Regulation, restricting the use of M-N-MA.

Reasonable periods of time will be granted to the industry in order to make the necessary adjustments to product formulations and comply with new requirements and withdraw cosmetic products which do not comply with those requirements.

The European Cosmetics Regulation is considered one of the most complex in the world and being up to date can be a hard task. Critical Catalyst is here to help you. Feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Commission Regulation (EU) 2022/135 of 31 January 2022 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use of Methyl-N-methylanthranilate in cosmetic products.

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »